Molecular analysis of the HuD gene in neuroendocrine lung cancers

Lung Cancer

Volumn 67, Issue 1, 2010, Pages 69-75

  D'Alessandro, Vito ^a   Muscarella, Lucia Anna ^a   la Torre, Annamaria ^a   Bisceglia, Michele ^a   Parrella, Paola ^a   Scaramuzzi, Gerardo ^a   Storlazzi, Clelia Tiziana ^b   Trombetta, Domenico ^b   Kok, Klaas ^c   De Cata, Angelo ^a   Sperandeo, Marco ^a   Zelante, Leopoldo ^a   Carella, Massimo ^a   Vendemiale, Gianluigi ^a,d  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Carcinoid; ELAV like; HuD; Lung cancer; Mutation; Neuroendocrine tumor; SCLC

Indexed keywords

PROTEIN HUD; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER TISSUE; CARCINOID; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; FRAMESHIFT MUTATION; GENE SEQUENCE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG CARCINOGENESIS; LUNG CARCINOMA; LUNG SMALL CELL CANCER; MALE; MOLECULAR CLONING; MOLECULAR GENETICS; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; SOMATIC MUTATION; STOP CODON;

AMINO ACID SEQUENCE; CARCINOMA, NEUROENDOCRINE; DNA MUTATIONAL ANALYSIS; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; MUTATION; SMALL CELL LUNG CARCINOMA;

EID: 71549127741     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.03.022     Document Type: Article

References (36)

1. Yao K.M., Samson M.L., Reeves R., and White K. Gene elav of Drosophila melanogaster: a prototype for neuronal-specific RNA binding protein gene family that is conserved in flies and humans. J Neurobiol 24 (1993) 723-739
2. Marusich M.F., Furneaux H.M., Henion P.D., and Weston J.A. Hu neuronal proteins are expressed in proliferating neurogenic cells. J Neurobiol 25 2 (1994) 143-155
3. Antic D., and Keene J.D. Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression. Am J Hum Genet 61 2 (1997) 273-278
4. Szabo A., Dalmau J., Manley G., Rosenfeld M., Wong E., Henson J., Posner J.B., and Furneaux H.M. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and sex-lethal. Cell 67 (1991) 325-333
5. King P.H., Levine T.D., Fremeau R.T., and Keene J.D. Mammalian homologs of Drosophila ELAV localized to a neuronal subset can bind in vitro to the 3′ UTR of mRNA encoding the Id transcriptional repressor. J Neurosci 14 (1994) 1943-1952
6. Sakai K., Gofuku M., Kitagawa Y., Ogasawara T., Hirose G., Yamazaki M., Koh C.S., Yanagisawa N., and Steinman L. A hippocampal protein associated with paraneoplastic neurologic syndrome and small cell lung carcinoma. Biochem Biophys Res Commun 199 (1994) 1200-1208
7. Ma W.-J., Cheng S., Campbell C., Wright A., and Furneaux H. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem 271 (1996) 8144-8151
8. Wakamatsu Y., and Weston J.A. Sequential expression and role of Hu RNA-binding proteins during neurogenesis. Development 124 17 (1997) 3449-3460
9. Barami K., Iversen K., Furneaux H., and Goldman S. Hu protein as an early marker of neuronal phenotypic differentiation by subependymal zone cells of the adult songbird forebrain. J Neurobiol 28 (1995) 82-101
10. Birney E., Kumar S., and Krainer A.R. Analysis of the RNA-recognition motif and RS and RGG domains: conservation in metazoan pre-mRNA splicing factors. Nucleic Acids Res 21 (1993) 5803-5816
11. Gultekin S.H., Rosai J., Demopoulos A., Graus Y.F., Posner J.B., Dalmau J., and Rosemblum M.K. Hu immunolabeling as a marker of neural and neuroendocrine differentiation in normal and neoplastic human tissues: assessment using a recombinant anti-Hu Fab fragment. Int J Surg Pathol 8 2 (2000) 109-117
12. Manley G.T., Smitt P.S., Dalmau J., and Posner J.B. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites. Ann Neurol 38 (1995) 102-110
13. D'Alessandro V., Muscarella L.A., Copetti M., Zelante L., Carella M., and Vendemiale G. Molecular detection of neuron-specific ELAV-like-positive cells in the peripheral blood of patients with small-cell lung cancer. Cell Oncol 30 (2008) 291-297
14. Carpentier A.F., Voltz R., DesChamps T., Posner J.B., Dalmau J., and Rosenfeld M.R. Absence of HuD gene mutations in paraneoplastic small cell lung cancer tissue. Neurology 50 6 (1998) 1919
15. Sekido Y., Bader S.A., Carbone D.P., Johnson B.E., and Minna J.D. Molecular analysis of the HuD gene encoding a paraneoplastic encephalomyelitis antigen in human lung cancer cell lines. Cancer Res 54 (1994) 4988-4992
16. Travis W.D., Brambilla E., Muller-Hermelink H.K., and Harris C.C. World Health Organization classification of tumours. Pathology and genetics. Tumours of lung, pleural, thymus and heart (2004), IARC Press, Lyon
17. Parrella P., Sidransky D., and Merbs S.L. Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway. Cancer Res 13 (1999) 3032-3037
18. Skotheim R.I., Diep C.B., Kraggerud S.M., Jakobsen K.S., and Lothe R.A. Evaluation of loss of heterozygosity/allelic imbalance scoring in tumor DNA. Cancer Genet Cytogenet 1 (2001) 64-70
19. Chung S., Jiang L., Cheng S., and Furneaux H. Purification and properties of HuD, a neuronal RNA-binding protein. J Biol Chem 271 (1996) 11518-11524
20. Ma W.J., Chung S., and Furneaux H. The Elav-like proteins bind to AU-rich elements and to the poly(A) tail of mRNA. Nucleic Acids Res 25 (1997) 3564-3569
21. Fan X.C., and Steitz J.A. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J 17 (1998) 3448-3460
22. Abe R., Sakashita E., Yamamoto K., and Sakamoto H. Two different RNA binding activities for the AU-rich element and the poly(A) sequence of the mouse neuronal protein mHuC. Nucleic Acids Res 24 (1996) 4895-4901
23. Wang X., and Tanaka Hall T.M. Structural basis for recognition of AU-rich element RNA by the HuD protein. Nat Struct Biol 8 (2001) 141-145
24. Ng P.C., and Henikoff S. Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet 7 (2006) 61-80
25. Ullmann R., Petzmann S., Sharma A., Cagle P.T., and Popper H.H. Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung. Hum Pathol 32 (2001) 1059-1063
26. Jones M.H., Virtanen C., Honjoh D., Miyoshi T., Satoh Y., Okumura S., et al. Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small cell and large cell neuroendocrine carcinomas identified by gene expression profiles. Lancet 363 (2004) 775-781
27. Sampietro G., Tomasic G., Collini P., Biganzoli E., Boracchi P., Bidoli P., et al. Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis. Appl Immunohistochem Mol Morphol 8 (2000) 49-56
28. Anbazhagan R., Tihan T., Bornman D.M., Tohnston J.C., Saltz J.H., Weigering A., et al. Classification of small cell lung cancer and pulmonary carcinoid by gene expression profiles. Cancer Res 59 (1999) 5119-5122
29. Gazzeri S., Della Valle V., Chaussade L., Brambilla C., Larsen C.J., and Brambilla E. The human p19ARF protein encoded by the beta transcript of the p16INK4a gene is frequently lost in small cell lung cancer. Cancer Res 58 (1998) 3926-3931
30. Przygodzki R.M., Finkelstein S.D., Langer J.C., Swalsky P.A., Fishback N., Bakker A., et al. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors: correlation with histological subtype and clinical outcome. Am J Pathol 148 (1996) 1531-1541
31. Kovatich A., Friedland D.M., Druck T., Hadaczek P., Huebner K., Comis R.L., et al. Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumors. Cancer 83 (1998) 1109-1117
32. Wang D.-G., Johnston C.F., Sloan J.M., and Buchanan K.D. Expression of bcl-2 in lung neuroendocrine tumours: comparison with p53. J Pathol 184 (1998) 247-251
33. Cagle P.T., el-Naggar A.K., Xu H.J., Hu S.X., and Benedict W.F. Differential retinoblastoma protein expression in neuroendocrine tumors of the lung: potential diagnostic implications. Am J Pathol 150 (1997) 393-400
34. King P.H. Differential expression of the neuroendocrine genes Hel-N1 and HuD in small-cell lung carcinoma: evidence for down-regulation of the HuD in the variant phenotype. Int J Cancer 74 (1997) 378-382
35. Jull B.A., Plummer III H.K., and Schuller H.M. Nicotinic receptor-mediated activation by tobacco-specific nitrosamine NNK of a Raf-1/MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells. J Cancer Res Clin Oncol 127 (2001) 707-717
36. Fink G., Krelbaum T., Yellin A., Bendayan D., Sante M., Glazer M., et al. Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from literature. Chest 119 (2001) 1647-1651